热门资讯> 正文
GOEV、NBSE和FLGC在上市前的输家中
2024-03-26 20:15
- Losers: NeuBase Therapeutics (NBSE) -58%.
- AppTech Payments Corp (APCX) -41% announces proposed underwritten public offering.
- Ampio Pharmaceuticals (AMPE) -38% announces voluntary delisting and SEC deregistration.
- Tivic Health Systems (TIVC) -16% after Q3 earnings release.
- Cardlytics (CDLX) -12% on proposed $150M convertible notes offering.
- Dada Nexus Ltd (DADA) -11% after Q4 earnings release.
- eFFECTOR Therapeutics (EFTR) -8% after Q4 earnings release.
- Bioline Rx Ltd (BLRX) -8% after FY earnings release.
- MAIA Biotechnology (MAIA) -7% looks to raise $1.33M through a private placement.
- Global Mofy Metaverse Ltd (GMM) -7%.
- MicroAlgo (MLGO) -7%.
- Canoo (GOEV) -6%.
- Flora Growth Corp (FLGC) -5%.
- Bluebird bio (BLUE) -5% reports Q4 results.
More on Pre-market losers & stocks.
- Canoo: Positive News Isn't Enough
- Canoo: Avoid After Reverse Stock Split
- Canoo: There Is A Glimpse Of Hope But Hold
- Canoo completes acquisition of manufacturing assets from Arrival
- Canoo's manufacturing facility gets foreign trade zone status; shares rise ~59%
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
